All news Halia touts positive early data in trial of inflammation-targeting therapeuticBy MichaelDecember 10, 2024 Promising data from Phase 2 study in myelodyspla Read More
All news BioAge halts obesity trial after safety concernsBy MichaelDecember 9, 2024 Company continues to advance NLRP3 neuroinflamma Read More
All news Denmark spawns the latest player in next-gen obesity drug developmentBy MichaelDecember 9, 2024 Antag lands €80m to advance GIPR antagonist ap Read More
All news Vitalist Bay: A new beacon for longevity innovation and collaborationBy MichaelDecember 9, 2024 World’s largest longevity event combines longe Read More
All news LSF to advance female fertility research with targeted fundingBy MichaelDecember 9, 2024 Funding call for innovative scientific proposals Read More
All news Health is the foundation of greatness: Kayla Barnes-Lentz on brain optimization and longevityBy MichaelDecember 9, 2024 Read More All news Longevity Clinics: Pioneering the future of health and wellnessBy MichaelDecember 7, 2024 The Longevity Clinics panel session at this year Read More All news Full-body MRI study emphasizes link between diabetes and cognitive declineBy MichaelDecember 6, 2024 Prenuvo study links Type 2 diabetes to reduction Read More All news Ten Levels of Longevity : #3 longevity supplementsBy MichaelDecember 6, 2024 How supplements are reshaping healthspan strateg Read More All news Jupiter IPOs to advance resveratrol-based treatments for neuroinflammationBy MichaelDecember 5, 2024 Company lists on Nasdaq, raising $11m to take pa Read More Previous 1 … 315 316 317 318 319 … 621 Next
All news Longevity Clinics: Pioneering the future of health and wellnessBy MichaelDecember 7, 2024 The Longevity Clinics panel session at this year Read More
All news Full-body MRI study emphasizes link between diabetes and cognitive declineBy MichaelDecember 6, 2024 Prenuvo study links Type 2 diabetes to reduction Read More
All news Ten Levels of Longevity : #3 longevity supplementsBy MichaelDecember 6, 2024 How supplements are reshaping healthspan strateg Read More
All news Jupiter IPOs to advance resveratrol-based treatments for neuroinflammationBy MichaelDecember 5, 2024 Company lists on Nasdaq, raising $11m to take pa Read More
